18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: Comparison with MR imaging and validation with surgical specimen

Neuroradiology

Volumn 51, Issue 10, 2009, Pages 677-686

  Seitz, Oliver ^a   Chambron Pinho, Nicole ^a   Middendorp, Markus ^a   Sader, Rober ^a   MacK, Martin ^a   Vogl, Thomas J ^a   Bisdas, Sotirios ^b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Gross tumor volume; MRI; Oral cancer; Oropharynx; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; TUMOR VOLUME; VALIDATION STUDY; COMPARATIVE STUDY; LYMPH NODE; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349243056     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-009-0586-8     Document Type: Article

References (33)

1. RI Haddad DM Shin 2008 Recent advances in head and neck cancer N Engl J Med 359 1143 1154 18784104 10.1056/NEJMra0707975 1:CAS:528:DC%2BD1cXhtFWrsLvI
2. JP Pignon J Bourhis C Domenge, et al. 2000 Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 949 955 10768432 1:STN:280:DC%2BD3c3ivV2iuw%3D%3D
3. J Bourhis G Calais M Lapeyre, et al. 2004 Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French head and neck cancer group (GORTEC) Semin Oncol 31 822 826 15599861 10.1053/j.seminoncol.2004.09.002 1:STN:280:DC%2BD2cnisVCmtg%3D%3D (Pubitemid 39602689)
4. MR Kim JL Roh JS Kim, et al. 2007 Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx Eur J Surg Oncol 33 633 638 17391904 10.1016/j.ejso.2007.02.016 1:STN:280:DC%2BD2s3pvF2ktQ%3D%3D (Pubitemid 46746539)
5. R Abgral S Querellou G Potard, et al. 2009 Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 50 24 29 19091901 10.2967/jnumed.108.055806
6. SH Ng TC Yen CT Liao, et al. 2005 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation J Nucl Med 46 1136 1143 16000282
7. C Nahmias C Lemmens D Faul, et al. 2008 Does reducing CT artifacts from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer? J Nucl Med 49 1047 1052 18552154 10.2967/jnumed.107.049858 (Pubitemid 351948011)
8. CH Baek MK Chung YI Son, et al. 2008 Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images J Nucl Med 49 1422 1428 18703597 10.2967/jnumed.108.051649
9. KL Newbold M Partridge G Cook, et al. 2008 Evaluation of the role of 18FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer Acta Oncol 47 1229 1236 18661420 10.1080/02841860802256483 1:CAS:528:DC%2BD1cXhtVOrtb3K
10. MR Vernon M Maheshwari CJ Schultz, et al. 2008 Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma Int J Radiat Oncol Biol Phys 70 678 684 18262086
11. N Lee P Xia NJ Fischbein, et al. 2003 Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation Int J Radiat Oncol Biol Phys 57 49 60 12909215 10.1016/S0360- 3016(03)00583-2 (Pubitemid 37040930)
12. U Nestle S Kremp A Schaefer-Schuler, et al. 2005 Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer J Nucl Med 46 1342 1348 16085592
13. R Murakami H Uozumi T Hirai, et al. 2007 Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 68 377 382 17321066
14. T Vogl S Bisdas 2007 Lymph node staging Top Magn Reson Imaging 18 303 316 17893595 10.1097/RMR.0b013e3181570c5b (Pubitemid 47480733)
15. AJ Fleming Jr SP Smith Jr CM Paul, et al. 2007 Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients Laryngoscope 117 1173 1179 17603315 10.1097/MLG.0b013e31805d017b (Pubitemid 47015665)
16. C Greco SA Nehmeh H Schoder, et al. 2008 Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer Am J Clin Oncol 31 439 445 18838879 10.1097/COC.0b013e318168ef82
17. JF Daisne T Duprez B Weynand, et al. 2004 Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen Radiology 233 93 100 15317953 10.1148/radiol.2331030660 (Pubitemid 39280962)
18. JL Roh NK Yeo JS Kim, et al. 2007 Utility of 2-[18F] fluoro-2-deoxy-D- glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma Oral Oncol 43 887 893 17207656 10.1016/j.oraloncology.2006.10.011 (Pubitemid 47369251)
19. M Pentenero A Cistaro M Brusa, et al. 2008 Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma Head Neck 30 1488 1496 18767178 10.1002/hed.20906
20. DY Yoon HS Hwang SK Chang, et al. 2009 CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck Eur Radiol 19 634 642 18843493 10.1007/s00330-008-1192-6
21. H Schoder HW Yeung M Gonen, et al. 2004 Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion Radiology 231 65 72 14990824 10.1148/radiol.2311030271 (Pubitemid 38375411)
22. WJ Goodwin Jr 2000 Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110 1 18 10714711 10.1097/00005537-200003001-00001
23. SC Ong H Schoder NY Lee, et al. 2008 Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer J Nucl Med 49 532 540 18344440 10.2967/jnumed.107.044792
24. RS Andrade DE Heron B Degirmenci, et al. 2006 Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers Int J Radiat Oncol Biol Phys 65 1315 1322 16750327
25. K Kubota J Yokoyama K Yamaguchi, et al. 2004 FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT Eur J Nucl Med Mol Imaging 31 590 595 14722678 10.1007/s00259-003-1408-6
26. P Zbaren S Weidner HC Thoeny 2008 Laryngeal and hypopharyngeal carcinomas after (chemo)radiotherapy: a diagnostic dilemma Curr Opin Otolaryngol Head Neck Surg 16 147 153 18327034 10.1097/MOO.0b013e3282f702a9 (Pubitemid 351354970)
27. S Bisdas M Baghi F Huebner, et al. 2007 In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck Eur Radiol 17 251 257 16703309 10.1007/s00330-006-0294-2 (Pubitemid 46063051)
28. N Fakhry D Lussato T Jacob, et al. 2007 Comparison between PET and PET/CT in recurrent head and neck cancer and clinical implications Eur Arch Otorhinolaryngol 264 531 538 17203307 10.1007/s00405-006-0225-5 (Pubitemid 46569959)
29. RJ Wong DT Lin H Schoder, et al. 2002 Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma J Clin Oncol 20 4199 4208 12377963 10.1200/JCO.2002.02.590 1:STN:280:DC%2BD38nitVOgtg%3D%3D (Pubitemid 35191022)
30. RB de Bondt PJ Nelemans PA Hofman, et al. 2007 Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging Eur J Radiol 64 266 272 17391885 10.1016/j.ejrad.2007.02.037 (Pubitemid 47588749)
31. PA Kyzas E Evangelou D Denaxa-Kyza, et al. 2008 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis J Natl Cancer Inst 100 712 720 18477804 10.1093/jnci/djn125
32. T Stuckensen AF Kovacs S Adams, et al. 2000 Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI J Craniomaxillofac Surg 28 319 324 11465137 1:STN:280:DC%2BD3MvhsV2muw%3D%3D
33. H Schoder DL Carlson DH Kraus, et al. 2006 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI J Nucl Med 47 755 762 16644744